$SMXT

SolarMax Technology, Inc. 2026: Revenue $10.24M, EPS ($0.98) — 10-Q Summary

SolarMax Technology, Inc. reported Q2 2026 revenue of $10.24M, up 48.8% YoY, but a net loss of ($4.66M), or ($0.98) EPS. Year-to-date revenue rose 81.6% to $25.1M, driven by solar and LED sales. Gross margin improved to 21.8% from 14.7% YoY, according to the company's 10-Q filing.

Original reporting
Published Oct 8, 2026, 10:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 10:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SolarMax Technology, Inc. 2026: Revenue $10.24M, EPS ($0.98) — 10-Q Summary — source image
Decision brief

The 30-second read

$SMXTBearishMed
01

Why it matters

The earnings miss may trigger short‑term price pressure, though the revenue upside could attract longer‑term interest.

02

Market read

Micro‑cap solar EPC stock with new earnings data; likely short‑term downside but potential upside on future contract wins.

03

What to watch

Long‑term EPC contract pipeline and SGIP program participation may improve profitability later.

Relevance 6/10Novelty 6/10Timing: after-hours

Background

SolarMax Technology filed its Q2 2026 Form 10‑Q, highlighting revenue growth from EPC projects and LED sales, but a deeper net loss.

Company-level read

Ticker impact

$SMXTBearishMedium confidence
Context

Q2 2026 10‑Q reports revenue $10.24M, net loss $4.66M, EPS -$0.98 versus prior year.

Expected impact

likely downside as investors price in larger loss and weak earnings per share.

Evidence & confidence

Loss widened 145% YoY despite 48.8% revenue increase, indicating margin pressure.

Market effects

Solar EPC and LED segments see modest revenue boost, but earnings weakness may dampen sector sentiment.

US solar installers could feel pressure if similar loss patterns emerge.

Limited impact beyond niche solar/EPC niche investors.

Counterpoint

If the loss is viewed as a temporary scaling cost, the stock could rebound on future margin expansion.

Key entities

  • SolarMax Technology, Inc.

    Micro‑cap solar and LED EPC provider.

Related articles

$SMXTMed

SolarMax Technology Inc.: SolarMax Technology Announces Reverse Stock Split to Support Effort to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

SolarMax Technology, Inc. (Nasdaq: SMXT) announced a 1-for-12 reverse stock split effective Aug. 13, 2026 to help regain Nasdaq’s $1 minimum bid price compliance. Nasdaq notified the company on Mar. 3, 2026; the 180-day period ends Aug. 31, 2026. The split reduces outstanding shares from 56.9M to about 4.74M and does not address the $35M market value rule.

$PHVSMedAI 8/10

Pharvaris HAE drug shows faster symptom relief in Lancet study

Pharvaris' phase 3 study of deucrictibant IR for HAE attacks, published in The Lancet, met all endpoints, showing faster symptom relief and resolution than placebo. The drug was well-tolerated. FDA and EMA reviews are ongoing with decisions expected in 2027. According to the company, the study results support the drug's efficacy and safety.

$PHVSMedAI 8/10

Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet

Pharvaris (PHVS) announced positive results from the RAPIDe-3 study of deucrictibant IR for treating HAE attacks, published in The Lancet. The treatment showed rapid symptom relief and resolution, with a well-tolerated safety profile. The company's NDA and MAA for deucrictibant IR are under regulatory review, with a PDUFA target date of April 23, 2027.